article thumbnail

Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure

Open Heart

Background Short-term improvements in quality of life (QOL) have been reported in adult congenital heart disease patients with systemic right ventricle (sRV) failure after treatment with sacubitril/valsartan. This study aimed to evaluate the medium-term QOL changes in sRV failure patients treated with sacubitril/valsartan.

article thumbnail

Impact of COVID-19 on patients awaiting ablation for atrial fibrillation

Open Heart

Objective Atrial fibrillation (AF) ablation services were significantly affected by the COVID-19 pandemic. We aimed to evaluate a symptom-based clinician prioritisation scheme for waiting list management compared with patient-completed quality of life (QoL) scores. –74.1;

article thumbnail

Atrial fibrillation and COVID-19: an analysis of the ambulatory database

Frontiers in Cardiovascular Medicine

It worsens the quality of life of patients, leads to an increase in the mortality rate because of its association with a high risk of thromboembolic complications. Atrial fibrillation (AF) is the most common heart rhythm disorder in clinical practice. However, most research in this area has focused on hospital patients.

article thumbnail

Digital Consults to Enhance Heart Failure Treatment: The ADMINISTER Trial

Cardiology Update

The COVID-19 pandemic highlighted the potential of video consults (VCs), even among older patients, to support self-care, improve disease management, and facilitate collaboration with caregivers. Digital consults (DCs) offer a promising solution to enhance GDMT optimization for the growing HF population. Original article: Man JP et al.

article thumbnail

Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection

Open Heart

Background Long COVID is associated with multiple symptoms and impairment in multiple organs. Using cardiac MR (CMR), we investigated a 12-month trajectory of abnormalities in Long COVID. since first post-COVID-19 symptoms. Cardiac-related blood biomarkers could not identify CMR abnormalities in Long COVID.

article thumbnail

TAVR Found Non-Inferior to SAVR for Low-Risk Patients

DAIC

In addition, the COVID-19 pandemic might have amplified the surgical risk. Future analyses will include additional metrics for assessing clinical superiority as well as quality of life outcomes. “Although we primarily tested for non-inferiority, the magnitude of the difference surprised us,” Seiffert said.

TAVR 111
article thumbnail

Effect of psychosocial aspects on medication adherence in patients with heart failure amid socioeconomic challenges

Open Heart

Objective To evaluate stress, depression and quality of life among community-dwelling patients with heart failure (HF) and evaluate their effect on perceived medication adherence in a socioeconomically challenged setting. were on ACE inhibitors/angiotensin receptor blockers and 54.9% on beta-blockers.